NCT00572052View on ClinicalTrials.gov

Comparison of Glycemic Control Achieved With 2 Different Needles

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems
Interventions
DEVICE

NovoFine® needle 6 mm

DEVICE

Ultra-Fine needle 12.7 mm

Trial Locations (5)

45429

Novo Nordisk Investigational Site, Kettering

78229

Novo Nordisk Investigational Site, San Antonio

94598

Novo Nordisk Investigational Site, Walnut Creek

08009

Novo Nordisk Investigational Site, Berlin

08648

Novo Nordisk Investigational Site, Lawrenceville

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY